triazolam has been researched along with Cognition Disorders in 7 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thus ketamine does not produce the underestimation of cognitive impairment typically seen with triazolam." | 2.78 | Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers. ( Carter, LP; Griffiths, RR; Kleykamp, BA; Mintzer, MZ, 2013) |
| "Triazolam was associated with longer total sleep time and increased Stage 2 sleep." | 1.36 | Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. ( Kehne, JH; Malison, RT; Morgan, PT; Sprenger, KJ, 2010) |
| "We report two cases of severe withdrawal symptoms after abrupt discontinuation of a long-term normal-dose benzodiazepines (BZD) administration." | 1.27 | [Two cases of psychotic state following normal-dose benzodiazepine withdrawal]. ( Tani, Y; Terao, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morgan, PT | 1 |
| Kehne, JH | 1 |
| Sprenger, KJ | 1 |
| Malison, RT | 1 |
| Carter, LP | 1 |
| Kleykamp, BA | 1 |
| Griffiths, RR | 1 |
| Mintzer, MZ | 1 |
| Cotroneo, A | 1 |
| Gareri, P | 1 |
| Nicoletti, N | 1 |
| Lacava, R | 1 |
| Grassone, D | 1 |
| Maina, E | 1 |
| De Sarro, G | 1 |
| Cabodi, S | 1 |
| Patat, A | 1 |
| Klein, MJ | 1 |
| Surjus, A | 1 |
| Hucher, M | 1 |
| Granier, J | 1 |
| Wysowski, DK | 1 |
| Barash, D | 1 |
| Terao, T | 1 |
| Tani, Y | 1 |
| Edwards, IR | 1 |
2 trials available for triazolam and Cognition Disorders
| Article | Year |
|---|---|
Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.
Topics: Adjuvants, Anesthesia; Administration, Oral; Adult; Anesthetics, Dissociative; Cognition; Cognition | 2013 |
Study of the potential reversal of triazolam memory and cognitive deficits by RU 41 656 in healthy subjects.
Topics: Adult; Attention; Cognition Disorders; Double-Blind Method; Emotions; Ergolines; Flicker Fusion; Hum | 1991 |
5 other studies available for triazolam and Cognition Disorders
| Article | Year |
|---|---|
Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
Topics: Adult; Arousal; Cognition Disorders; Disorders of Excessive Somnolence; Dose-Response Relationship, | 2010 |
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status | 2007 |
Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Cognition Disorders; Female; Humans; | 1991 |
[Two cases of psychotic state following normal-dose benzodiazepine withdrawal].
Topics: Anti-Anxiety Agents; Cognition Disorders; Female; Humans; Male; Middle Aged; Nitrazepam; Perceptual | 1988 |
Adverse reactions to vaginal pessaries, enalpril and triazolam.
Topics: Cognition Disorders; Confusion; Enalapril; Female; Humans; Hypotension; Male; Pessaries; Triazolam | 1985 |